India Finds Two More Toxic Syrups Months After Poisoning Deaths

NEW DELHI: India’s drug regulator has found that a cough syrup and an anti-allergy syrup made by Norris Medicines are toxic, according to a government report, months after Indian-made cough syrups were linked to 141 children’s deaths worldwide.

The Central Drugs Standard Control Organisation (CDSCO) has also found three batches of COLD OUT syrup made by Fourrts (India) Laboratories contaminated with the toxins diethylene glycol (DEG) and ethylene glycol (EG), according to its list of “not of standard quality/spurious/adulterated/misbranded” drugs for August uploaded on its website.

Total 11 samples were found contaminated with Ethylene Glycol and samples of Cyproheptadine HCl with Tricholine Citrate Syrup (Sylpro Plus Syrup) Batch No. 33002 and Cold Out Syrup Batch No. SF001A0 1 and SF001A0 2  Manufactured by Norris Medicines Limited, Plot No. 801/P, 901/4-5, G.I.D.C. Estate, Ankleshwar – 393 002 (Gujarat) found to contain Diethylene Glycol. 

The drug regulator for Gujarat state, where Norris is based, told Reuters that its factory had been closed.

Related Posts

  • Pharma
  • May 10, 2025
  • 84 views
Pharma sector continues to thrive, driven by price-led expansion

The Indian pharmaceutical market continued rising in April 2025, achieving a strong annual growth of 7.8%, with total sales reaching a remarkable Rs 19,711 crore. According to a report by…

  • Pharma
  • May 10, 2025
  • 81 views
TPG to acquire 35% stake in SCHOTT Poonawalla from SII

Mumbai:  SCHOTT Pharma has announced that TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in its joint venture SCHOTT Poonawalla…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma sector continues to thrive, driven by price-led expansion

Pharma sector continues to thrive, driven by price-led expansion

TPG to acquire 35% stake in SCHOTT Poonawalla from SII

TPG to acquire 35% stake in SCHOTT Poonawalla from SII

Indian pharma industry showed impressive growth in April 2025, by price led expansion: Report

Indian pharma industry showed impressive growth in April 2025, by price led expansion: Report

Diabetes drug shows promise for treating prostate cancer

Diabetes drug shows promise for treating prostate cancer